Address
Email address
https://euroapteek.eeE-apteek | Euroapteek.eeEuroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ PharmaEight
Registry code
14915163
VAT number
EE102233681
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
18.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
2 757 881 €
-72 016 €
-3%
2 414 €
(estimate is approximate)
-438 248 €
4
Submitted
No tax arrears
16%
-15%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: ANNE RAUDSEPING 22.10.1980 (43) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| Osaühing EUROAPTEEK 11036389 | - | - | - | Founder |
| 2020 30.06.2021 | 2021 20.06.2022 | 2022 14.06.2023 | 2023 17.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 1 668 261 € | 2 415 015 € | 2 748 728 € | 2 757 881 € |
| Net profit (loss) for the period | -246 546 € | 6 767 € | -128 954 € | -72 016 € |
| Profit Margin | -15% | 0% | -5% | -3% |
| Current Assets | 484 411 € | 559 895 € | 570 571 € | 416 292 € |
| Fixed Assets | 662 628 € | 590 486 € | 517 825 € | 75 848 € |
| Total Assets | 1 147 039 € | 1 150 381 € | 1 088 396 € | 492 140 € |
| Current Liabilities | 1 391 085 € | 1 387 660 € | 1 454 628 € | 930 388 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -244 046 € | -237 279 € | -366 232 € | -438 248 € |
| Employees | 2 | 2 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 528 780.04 € | 10 447.44 € | 11 818.67 € | 3 |
| 2023 Q4 | 815 625.29 € | 7 016.16 € | 15 101.56 € | 3 |
| 2023 Q3 | 624 019 € | 5 826.85 € | 18 128.27 € | 6 |
| 2023 Q2 | 677 823.16 € | 5 459.67 € | 16 406.18 € | 5 |
| 2023 Q1 | 728 672.17 € | 5 796.22 € | 15 058.9 € | 4 |
| 2022 Q4 | 739 458.39 € | 4 589.61 € | 15 147.79 € | 4 |
| 2022 Q3 | 616 632.67 € | 9 140.87 € | 15 879.67 € | 4 |
| 2022 Q2 | 663 882.51 € | - | 7 316.74 € | 4 |
| 2022 Q1 | 670 088.49 € | - | 7 868.97 € | 2 |
| 2021 Q4 | 699 041.33 € | 6 548.65 € | 6 738.98 € | 2 |
| 2021 Q3 | 530 876.7 € | - | 7 395.95 € | 2 |
| 2021 Q2 | 588 838.18 € | 6 793.91 € | 7 365.69 € | 2 |
| 2021 Q1 | 571 600.54 € | 7 318.55 € | 7 934.5 € | 2 |
| 2020 Q4 | 609 788.74 € | 10 387.66 € | 11 193.6 € | 2 |
| 2020 Q3 | 493 059.11 € | 13 625.31 € | 14 597.12 € | 4 |
| 2020 Q2 | 326 487.89 € | - | - | 4 |
| 2020 Q1 | - | - | - | - |
